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Abstract
Background: Less than 80 reported cases of paragangliomas of the larynx are reported in the literature. A role for
external beam radiation in this disease has not yet been explored. We present four cases of laryngeal
paragangliomas treated at a large tertiary-care cancer center over a 35-year period.
Methods: 124 cases of head and neck paragangliomas treated at a single institution from 1970 to 2005 were
retrospectively studied. Patients with laryngeal paragangliomas were identified, and a comprehensive clinico-
pathological review was undertaken.
Results: We identified 4 patients with tumors arising in the larynx at the following subsites: supraglottis (2), glottis
(1), and subglottis (1). Three patients were treated with surgery and one with definitive radiation alone.
Conclusions: Laryngeal paragangliomas are rare tumors and are adequately treated with surgical resection. We
also present one patient who was treated with radiation and had disease stabilization. Accurate histological
classification is critical, and the role of genetic testing is emerging.
Introduction
Paragangliomas of the laryngopharynx are rare tumors
that are of neuroendocrine origin and arise from the
neural crest-derived cells of the parasympathetic ner-
vous system. Since its first description in the literature
in 1955, fewer than 80 such cases have been reported
[1]. These benign lesions have a clinical course marked
by slow growth, with symptoms often mimicking those
of a squamous cell carcinoma. Patients present with
hoarseness or dysphasia, and a submucosal mass is evi-
dent on physical examination. The majority of these
tumors arise in the supraglottic larynx, and 2% of these
are malignant [1-3]. Since these tumors are from neural
crest-derived cells, they usually appear adjacent to nerve
structures, most commonly the superior laryngeal nerve
or the recurrent laryngeal nerve[4]. While surgical resec-
tion is often curative, this approach is based upon small
case series and retrospective data. Limited data is avail-
able on the role of external beam radiation therapy for
the management of this disease. While radiation therapy
has been utilized for the more common jugulo-tympanic
paragangliomas, this modality has received little
attention as a laryngeal preservation approach. In this
study, we reviewed a single-institutional experience with
laryngeal paragangliomas treated over a 35-year period.
Methods - Study Design and Setting
All laryngeal paragangliomas treated at the University of
Texas M.D. Anderson Cancer Center over the last
35 years were reviewed after IRB approval was obtained.
We identified 124 patients with cervical paragangliomas,
five of whom had tumors localized to the laryngophar-
ynx. One patient presented to M.D. Anderson for a sec-
ond opinion for a hypopharyngeal paraganglioma. This
patient was eliminated from our study as he was lost to
follow-up. Pathology reports, operative notes, video stro-
boscopic films and reports, radiologic imaging, and all
clinical notes were reviewed for the remaining patients.




A 67-year-old woman presented with voice changes. On
flexible endoscopy, a submucosal mass was seen extend-
ing through the glottic aperture. The patient underwent
an incisional biopsy, which revealed a paraganglioma by
* Correspondence: mekupfer@mdanderson.org
2Department of Head and Neck Surgery, The University of Texas M.D.
Anderson Cancer Center, 1400 Pressler, Unit 1445, Houston, TX 77030, USA
Smolarz et al. Head Neck Oncology 2010, 2:2
http://www.headandneckoncology.org/content/2/1/2
© 2010 Smolarz et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
immunohistochemical and histopathological criteria.
The patient was taken for surgery, and a direct laryngo-
scopy revealed a tumor originating in the subglottis,
extending to the vocal folds at the anterior commissure.
Due to the large pushing borders of the tumor that
caused extensive damage to the thyroid and cricoid car-
tilage, a total laryngectomy was performed. Cartilage
destruction with no apparent invasion of the larynx
from the paraganglioma was evident on histologic eva-
luation. The patient remained free of disease and
deceased from other causes two years later.
Case No. 2
A-50 year-old man presented with a recurrent mass of
the left supraglottic larynx that had been treated with a
supraglottic laryngectomy eight months prior to presen-
tation at our institution. A review of the pathology
revealed a paraganglioma. He was treated with a total
laryngectomy, but eight months after surgery, he pre-
sented with histologically-confirmed bilateral lung
metastasis and brain metastasis. He was treated with
systemic chemotherapy but ultimately developed spinal
metastases and progressive pulmonary disease. The
patient ultimately died from his disease 16 months after
diagnosis.
Case No. 3
An 85-year-old woman presented to an outside institu-
tion with a two-year history of cough. A supraglottic
lesion was noted on axial imaging of the neck, and a
biopsy revealed a spindle cell neoplasm. This lesion was
followed for one year, but the patient presented to our
institution with progression of her disease, which
included worsening of cough, new onset of hoarseness,
and dysphasia with symptoms of aspiration. On flexible
laryngoscopy, the patient had a right laryngeal mass
emanating from the right false cord and extended to the
aryepiglottic fold and epiglottis (Figure 1). Although sur-
gery was recommended, the patient opted for external
beam radiation. After five years of follow-up, the larynx
lesion was still present as a pale 2 mm cystic area on
the right aryepiglottic fold and had not grown in size
since the radiation treatment.
Case No. 4
A 39-year-old black female was noted to have an asymp-
tomatic glottic lesion at the time of a laparoscopic cho-
lecystectomy for cholelithiasis. Intubation was
performed without incident, though approximately one
week later, she developed shortness of breath and airway
compromise. A tracheostomy was placed at an outside
facility. She subsequently underwent a panendoscopy
and biopsy. On laryngoscopy, the lesion extended from
the posterior aspect of the left arytenoid to along the
aryepiglottic fold and false vocal cord onto the epiglottis
(Figure 2). On CAT scan of the neck, axial imaging
revealed an infiltrative and destructive mass of the left
hemi-larynx. The enhancing tumor measured approxi-
mately 2.5 cm in AP dimension, 3 cm in width, and
about 6 cm in height. The left subglottic component of
the tumor probably extended for about 3-5 mm below
the level of the true vocal cord (Figure 3). The patient
subsequently underwent an extended supraglottic laryn-
gectomy. Immunohistochemical stains for S-100, chro-
mogranin, and synaptophysin were positive. Stains for
pancytokeratin, EMA, and inhibin were negative. This
immunohistochemical profile substantiated the diagnosis
of paraganglioma (Figure 4). The patient was decannu-
lated one month after surgery. On last follow-up 10
months after her operation, she had no evidence of dis-
ease. Furthermore, she had no difficulties with dysphasia
or odynophagia, and the patient had functional speech
with baseline hoarseness.
Discussion
A report in 1994 by Ferlito et al critically evaluated all
of the reported paragangliomas of the larynx and found
that only 62 of these cases met their criteria for this
diagnosis [1-3]. Since then, 14 more cases have been
described in the surgical literature [5]. We add four
more cases to the literature of laryngeal paragangliomas
and report a single-institution experience with these
rare lesions (Table 1).
The management of laryngeal paraganglioma is usually
surgical, and it often entails total laryngectomy. In
selected cases, conservation surgical approaches have
been suggested for oncologic control. Partial laryngect-
omy is a reasonable option in selected cases, particularly
due to low likelihood of regional and distant metastasis
[1,6]. Varied surgical techniques can be used utilized for
laryngeal tumors, depending on the extent and site of
the tumor. Transoral resections can provide oncological
control for laryngeal tumors, though these approaches
for paragangliomas have been discouraged in the litera-
ture due to difficult access in a major bleed [6]. Some
authors advocate an external approach for excisional
biopsy so the mucosa of the airway is not violated
[3,6,7]. The anatomic considerations for partial laryn-
gectomy are consistent with the operative approaches
necessary for squamous cell histologies. However, due
to the rarity of malignant paraganglioma of the larynx, a
borderline tumor may be treated with a less extensive
surgery, unlike squamous cell carcinoma. However, utili-
zation of this treatment paradigm must be tempered by
the skills of the surgeon and the reliability of the patient
for intense post-operative surveillance.
A total of 23 inferior laryngeal paragangliomas have
been reported in the literature, 11 of which presented in
the subglottis. The other 12 presented as thyroid
masses. Two patients with subglottic tumors required
total laryngectomy, two required airway reconstruction,
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and one patient had recurrence [8]. These lesions that
present in the subglottis have more dyspnea and short-
ness of breath and need careful consideration for airway
management pre-operatively [7,9]. In our cohort, the
patient with a subglottic paraganglioma required a total
laryngectomy as the primary treatment. A conservation
laryngeal approach was not attempted due to radio-
graphic evidence of cartilage involvement without a
clear plane for resection. Though recurrence rate is 4%
in inferior laryngeal paraganglioma versus 17% reported
for superior laryngeal paragangliomas, careful follow-up
should be given to the inferior laryngeal cases due to
the potential for rapid airway obstruction with recurrent
or persistent disease [7,8].
Although paragangliomas are generally benign tumors
[10], malignant paragangliomas have been reported with
an incidence of 2% in some series [1-3]. However,
pathologic findings cannot predict clinical behavior
which requires metastases for designation as malignant.
While the incidence of metastasis was initially reported
to be as high as 25%, the critical review of Ferlito sug-
gested that most of these tumors may indeed have been
other histologies, including atypical carcinoid tumors,
on further pathological review [1,3,5,11,12]. In Case No.
2, an excisional biopsy was preformed, and the initial
diagnosis was malignant melanoma, nodular type, at an
outside hospital. The pathological findings after the
supraglottic laryngectomy were determined to be amela-
notic melanoma as well. Even after the laryngectomy,
the preliminary diagnosis was still the same. However, it
was not until electron microscopy revealed paragan-
glioma of the larynx that the final diagnosis was deter-
mined. In Case No. 3, an outside pathology report
revealed spindle cell tumor, but electron microscopy
determined that the lesion was, in fact, paraganglioma.
Malignant paragangliomas more commonly metasta-
size distantly and rarely spread to the lateral neck lymph
nodes. Thus, an elective neck dissection in a No neck
Figure 1 Case No. 3 (A) Pretreatment stroboscopy revealed tumor involvement in the right AE fold, extending down into the right
piriform sinus (B) Post-radiation - Only a small remnant of tumor remained after radiation and continued to be stable throughout
follow-up.
Figure 2 Case No. 4 (A) A large laryngeal paraganglioma is noted in the left arytenoid area. (B) There is involvement of the laryngeal and
lingual surfaces of the epiglottis.
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Figure 3 Case No. 4 - (A) Epiglottic extension (B) Tumor pushing the airway to the right (C) Near-total laryngeal obstruction (D)
Extension of tumor is found in the left anterior subglottis.
Figure 4 Case No. 4 (A) Overlying squamous epithelium with the tumor in the submucosa. The circular focus is a post-embolized vessel.
(B) Higher power 400× - Zellballen nests of tumor cells with thin supporting sustenacular cells around each nest.
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with a biopsy confirmed malignant laryngeal paragan-
glioma is generally not advocated [1,2]. In our series,
the single patient with cervical lymph node metastasis
also developed distant metastases. Although a salvage
total laryngectomy for local recurrence was performed,
the patient ultimately succumbed to his disease.
As previously observed by multiple groups, neither
radiation nor chemotherapy has been used successfully
as an alternative to surgery in the management of laryn-
geal paragangliomas [2,5,13,14]. For the more common
cervical paragangliomas, external beam radiation pro-
vides approximately 90% tumor control rate [15]. Our
patient was monitored for five years and revealed reduc-
tion of the tumor mass without tumor progression after
treatment with radiation.
The importance of genetic testing for mutations in the
SHDB, SDHC, and SHDD genes has recently been high-
lighted [16]. Mutations in the VHL and NF1 genes are
also associated with inherited paragangliomas. In parti-
cular, patients with SDHB mutations are at higher risk
for developing malignant paragangliomas [17]. To date,
there are only two cases of laryngeal paraganglioma that
have been associated with multicentric head and neck
paraganglioma syndrome. Though these particular
patients did not undergo genetic testing, it is probable
that gene mutations were the cause of multiple paragan-
gliomas [18].
Conclusion
Laryngopharyngeal paragangliomas are uncommon
tumors that are conventionally treated with surgical resec-
tion for oncologic control. Close collaboration with an
experienced pathologist is necessary to establish the diag-
nosis with immunohistochemical evaluation and electron
microscopy to confirm the diagnosis. The evolving role of
genetic testing is not defined, but it is likely that these four
reported cases are sporadic. Surgical resection remains the
standard of care for their treatment, although radiotherapy
may be considered in selected patients. Close observation
with serial imaging is necessary if this treatment approach
is undertaken. Although malignant paragangliomas of the
larynx have been reported, they are rare and metastasis
should raise the question of misdiagnosis. Multi-institu-
tional collaboration may provide greater insight into the
true biological behavior of this disease and help optimize
treatment approaches.
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